Nkarta (NKTX) Times Interest Earned (2019 - 2026)
Nkarta (NKTX) posted quarterly Times Interest Earned of -$5.15 for Q1 2026, up 21.88% year-over-year from -$4.22 in Q1 2025, and down 1.17% quarter-over-quarter from -$5.09 in Q4 2025.
Nkarta (NKTX) Times Interest Earned (2019 - 2026) Analysis & Trends
Nkarta's Times Interest Earned history runs 8 years deep, the most recent figure standing at -$5.15 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 21.88% year-over-year to -$5.15; the TTM figure through Mar 2026 stood at -$5.19 (down 27.0% YoY), while the FY2025 annual figure was -$0.81, up 87.21% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$5.15, down from -$5.09 in the prior quarter.
- The five-year high for Times Interest Earned was -$0.2 in Q3 2023, with the low at -$43.5 in Q1 2022.
- The 5-year median for Times Interest Earned is -$5.09 (2025), against an average of -$5.76.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned jumped 97.66% in 2022, then slumped 2562.48% in 2024.
- Nkarta's Times Interest Earned stood at -$8.77 in 2022, then soared by 77.43% to -$1.98 in 2023, then plunged by 227.15% to -$6.48 in 2024, then gained by 21.49% to -$5.09 in 2025, then decreased by 1.17% to -$5.15 in 2026.
- Business Quant data shows NKTX's Times Interest Earned at -$5.15 in Q1 2026, -$5.09 in Q4 2025, and -$0.74 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Nkarta | 201.14 Mn | 201.14 Mn | - | -6.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.41 |
| Mar 31, 2026 | -5.15 |
| Dec 31, 2025 | -5.09 |
| Sep 30, 2025 | -0.74 |
| Jun 30, 2025 | -0.70 |
| Mar 31, 2025 | -6.59 |
| Dec 31, 2024 | -6.48 |
| Sep 30, 2024 | -5.43 |
| Jun 30, 2024 | -5.33 |
| Mar 31, 2024 | -1.06 |
| Dec 31, 2023 | -1.98 |
| Sep 30, 2023 | -0.20 |
| Jun 30, 2023 | -0.25 |
| Mar 31, 2023 | -5.92 |
| Dec 31, 2022 | -8.77 |
| Sep 30, 2022 | -0.50 |
| Jun 30, 2022 | -0.23 |
| Mar 31, 2022 | -43.50 |
| Dec 31, 2021 | -35.82 |
| Sep 30, 2021 | -1.29 |